FUKUDA DENSHI USA, INC.
2 recall(s) on record — most severe on record: Class II.
Activity by year
- Recalls (2)
- Inspections (1)
Devices registered here (1)
- Detector And Alarm, ArrhythmiaProduct code DSI (opens in a new tab) · Class II · Cardiovascular · 21 CFR 870.1025
Recalls & enforcement
- Class IICompleted2017-10-16For the Fukuda Denshi patient monitor model DS-8100, in less than 0.003% (17) of the 6227 devices sold worldwide, a Short-term Battery Error message has appeared and has been traced back to a bad (damaged) Lithium-Ion capacitor (Short-term battery backup).
- Class IITerminated2015-12-21A possible malfunction where a Short-term Battery Error message has appeared and has been traced back to a bad (damaged) Lithium-Ion capacitor (Short-term Backup battery).
FDA inspections (1)
- NAI2024-03-26No Action Indicated · Compliance: Devices
Source: U.S. FDA Inspections Dashboard (opens in a new tab) (device inspection classifications, 2016–present). Data as of 2026-10-06. The dashboard profile can take several seconds to load.
Related
- All facilities operated by Fukuda Denshi Co., Ltd.
- FUKUDA DENSHI CO., LTD. (JP)
- FUKUDA DENSHI CO., LTD. (JP)
- Fukuda Denshi Finetech Sendai Co., Ltd. (JP)
Source: U.S. FDA via openFDA (opens in a new tab) (device registration & enforcement). Data as of 2026-10-06. Verify this facility record at FDA → (opens in a new tab)
Cite this record
RegWarden. “FUKUDA DENSHI USA, INC. (FEI 3000215024) — FDA facility record.” Compiled from U.S. FDA public records (openFDA; FDA Data Dashboard). Data as of 2026-10-06. https://regwarden.com/facility/3000215024-fukuda-denshi-usa-inc/
Alerts for FUKUDA DENSHI USA, INC.
Watchlist alerts will email you when FDA publishes a new recall, inspection classification, or warning letter for a facility you follow. They aren't open to the public yet — leave your email and we'll tell you when they are.
Want a one-page facility brief?
A single-page summary of this facility's registration and recall history for diligence. Not selling it yet — register interest and we'll follow up.